Training and IQ Rise Time Equipment Stig. Can be done remote via Skype or on-site. Request preference. The IQ results in a wet-ink protocol. The user gets a license to copyrighted text for e.g. internal maintenance work.

Manage Inhalation Profiles in Clinical Studies with MIDAS The powerful and versatile MIDAS (Manage Inhalation Data Automatically and Securely) is a cGCP compliant software for patient training purposes that can be used to:

• Streamline recording of thousands of profiles together with the Stig PL instrument
• Review, compare and perform mathematical operations on the profiles
• Create comprehensive reports, securely archived alongside the original data
• In addition, MIDAS can also record in-situ profiles from breath simulators in your lab.

The Midas provides a powerful means of recording the inhalation profiles of study subjects in clinical trials and making them available for review and reporting.

The application has been designed to operate in a dedicated IT framework, available from FIA. The scope of the overall system is to record, manage, report and archive data and signed reports in compliance with the highest cGCP standards whilst meeting the ERES requirements of 21 CFR Part 11.

MIDAS Application is for Everyone!

Application functionality is defined by user privileges. A user only sees what is relevant and appropriate for their role. Different functions are available in sections organised under tabs, following a workflow from left to right.

Read more in the pdf AB FIA_MIDAS_2025

This FIA product addresses the dynamics of testing dry-powder inhalers (DPIs). Compendial methods of testing DPIs call for an abrupt start and abrupt end to the air flow. An attribute aimed at representing the way a patient uses a DPI. The starting and stopping of the air flow introduces time-variant conditions in the test equipment (cascade impactor) and in the device itself. Experimental and computational studies of these conditions are continuing to elucidate the important characteristics of the device and test system that should be known and controlled to establish a sound quality control test for products that are or are about to be registered. FIA's latest instrument known as Stig puts in users hands the most important measure of the time-dependent air flow start-up the rise-time. It is important that the rise-time is known and under control when testing inhalable devices. Russell-Graham and colleagues¹showed that the fine particle dose increases as the rise time decreases. Previous and subsequent theoretical analyses point out reasons for this effect.^{2, 3} For established products quality control (QC) testing requires knowing that the rise-time remains in a specified range...now possible with Stig. For GMP QC Stig can be locked to acquire and present the rise-time according to a defined and validated method. Since patients do generate different inhalation air-flow profiles it is also important during the development of a new drug product to adjust the prototype devices to exhibit a sensible rise-time close to what will take place in patient use. This mindset is equally important for DPIs and for breath-actuated MDI devices. Stig also makes possible the recording of air-flow profiles so that they can be reproduced on a breathing simulator (such as F-SIG 6300) for studying nebulizers. Versatile and user-friendly. Best-in-class - that is the new Stig from FIA.

Key features of Stig:

• Rise-time measurement 0.1-1 s using a thermal flow meter
• Average rise-time from a series of measurements
• Touch-screen which displays a graph of flow vs. time, rise-time and the final flow
• Printed records of the measurement with optional printer. Has been validated together with Mettler-Toledo printers, customer can use own printers (e.g. from lab balances)
• Rise-time profile saved to USB-memory
• Date and time
• Battery powered
• Optional IQ/OQ and quality certificate for the regulated industry

Download the pdf Rise-time Measurement Instrument Stig

1. Russell-Graham, D., A. Cooper, B. Stobbs, E. McAulay, H. Bogard, V. Heith, E. Monsallier, "Further Evaluation of the Fast-Screening Impactor for Determining Fine-Particle Fraction of Dry Powder Inhalers, "Drug Delivery to the Lung, December 8 to 10, 2010, Edinburgh, Scotland.
2. Roberts, D. L., M. Chiruta, "Transient Impactor Behavior during the Testing of Dry-Powder Inhalers via Compendial Methods, "Drug Delivery to the Lung 18, The Aerosol Society, Edinburgh, Scotland, December 13-14, 2007.
3. Versteeg, H., P. Zhao, C. Blatchford, M. Copley, D. L. Roberts, J. P. Mitchell, "A Computational Fluid Dynamics (CFD) Model of the Start-Up Kinetics of the Andersen Cascade Impactor (ACI), "Drug Delivery to the Lung, Aerosol Society, Edinburgh, Scotland, December 9-11 2015; pages 18-21.